Aeglea Bio Therapeutics Probability of Future Stock Price Finishing Over 0.649

Aeglea Bio's future price is the expected price of Aeglea Bio instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Aeglea Bio Therapeutics performance during a given time horizon utilizing its historical volatility. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
  
Please specify Aeglea Bio's target price for which you would like Aeglea Bio odds to be computed.

Aeglea Bio Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Aeglea Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Aeglea Bio Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Aeglea Bio is not yet fully synchronised with the market data
Aeglea Bio has some characteristics of a very speculative penny stock
Aeglea Bio has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 2.33 M. Net Loss for the year was (83.81 M) with loss before overhead, payroll, taxes, and interest of (262 K).
Aeglea Bio Therapeutics currently holds about 73.68 M in cash with (80.14 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.2.
Over 98.0% of the company shares are held by institutions such as insurance companies

Aeglea Bio Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Aeglea Stock often depends not only on the future outlook of the current and potential Aeglea Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Aeglea Bio's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding3.4 M
Cash And Short Term Investments55.7 M

Aeglea Bio Technical Analysis

Aeglea Bio's future price can be derived by breaking down and analyzing its technical indicators over time. Aeglea Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Aeglea Bio Therapeutics. In general, you should focus on analyzing Aeglea Stock price patterns and their correlations with different microeconomic environments and drivers.

Aeglea Bio Predictive Forecast Models

Aeglea Bio's time-series forecasting models is one of many Aeglea Bio's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Aeglea Bio's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Aeglea Bio Therapeutics

Checking the ongoing alerts about Aeglea Bio for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Aeglea Bio Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Aeglea Bio is not yet fully synchronised with the market data
Aeglea Bio has some characteristics of a very speculative penny stock
Aeglea Bio has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 2.33 M. Net Loss for the year was (83.81 M) with loss before overhead, payroll, taxes, and interest of (262 K).
Aeglea Bio Therapeutics currently holds about 73.68 M in cash with (80.14 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.2.
Over 98.0% of the company shares are held by institutions such as insurance companies
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Consideration for investing in Aeglea Stock

If you are still planning to invest in Aeglea Bio Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aeglea Bio's history and understand the potential risks before investing.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets